Clinical trials are a very important part of medical research.
Our trials help researchers discover new effective treatments for mental health disorders such as depression, bipolar disorder, schizophrenia and anxiety; where we not only examine possible new medications for the alleviation of symptoms, but also alternative treatments, such as new psychotherapy techniques.
If you have questions about any particular study or participation in general, please contact the study co-ordinator or our main office.
The EMMAC study will assess the effect of MDMA and supportive talk therapy on depression and anxiety symptoms in patients with advanced stage cancer.
We are now recruiting patients for this study. Please contact the Principal Investigator, Professor Paul Glue if you are interested.
Dr Charlie Mentzel
Department of Psychological Medicine, Dunedin
We are now recruiting participants by provider referral for this trial.
Professor Bruce Russell
University of Otago School of Pharmacy
We are now recruiting patients for this trial.
Ketamine and behavioural activation therapy study (Ket- BAT )
A study comparing ketamine with ketamine and behavioural activation therapy (BAT) for treatment resistant depression.
We are looking for participants with treatment resistant depression from Dunedin and Christchurch. The study will commence in early 2024.
Dr Ben Beaglehole
Department of Psychological Medicine - Christchurch
Lead investigator for Dunedin
Prof Paul Glue
Department of Psychological Medicine - Dunedin
Study coordinator for Dunedin
Dr Shona Neehoff
Department of Psychological Medicine Dunedin
We are now recruiting patients for this study who live in either Dunedin or Christchurch.